Verification of the effect of lubiprostone on intestinal permeability in healthy volunteers

Trial Profile

Verification of the effect of lubiprostone on intestinal permeability in healthy volunteers

Active, no longer recruiting
Phase of Trial: Phase I

Latest Information Update: 17 May 2016

At a glance

  • Drugs Lubiprostone (Primary)
  • Indications Constipation; Irritable bowel syndrome
  • Focus Pharmacodynamics
  • Most Recent Events

    • 06 May 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top